Fellowship · Houston, TX
Sponsored by University of Texas Health Science Center at Houston
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
Leukemia · 2022 · 3,530 citations · Keyur Patel
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 935 citations · Funda Meric-Bernstam
The TRIPOD-LLM reporting guideline for studies using large language models.
Nature medicine · 2025 · 345 citations · Amy Moreno
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.
The New England journal of medicine · 2023 · 502 citations · Funda Meric-Bernstam
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
The New England journal of medicine · 2021 · 751 citations · Funda Meric-Bernstam
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group.
Annals of oncology : official journal of the European Society for Medical Oncology · 2024 · 316 citations ·
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials.
Nature medicine · 2023 · 334 citations · Funda Meric-Bernstam
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial.
Lancet (London, England) · 2026 · 35 citations · Amy Moreno